Web-based Rehab After Acute Vertigo

NCT05056324 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2025-03-30

No results posted yet for this study

Summary

Acute onset vertigo is common and entails much suffering with persisting symptoms at 3 months after onset in up to half of those afflicted. Vestibular rehabilitation to aid recovery is not readily available. The purpose of this study is to investigate the effects on vertigo symptoms of a 6-week online vestibular rehabilitation tool compared with standard care (written instructions leaflet) after acute onset vertigo.

Conditions

  • Acute Vestibular Syndrome

Interventions

DEVICE

Online vestibular rehabilitation tool

For those randomized to the intervention group, a 6 weeks duration vestibular rehabilitation will be delivered using an online tool (YrselTräning)

OTHER

Standard care (written instructions leaflet)

For those randomized to the control group, a 6 weeks duration standard vestibular rehabilitation will be delivered using a written instructions leaflet

Sponsors & Collaborators

  • University Hospital, Umeå

    collaborator OTHER
  • Sundsvall Hospital

    collaborator OTHER
  • Sahlgrenska University Hospital

    collaborator OTHER
  • Västernorrland County Council, Sweden

    collaborator OTHER_GOV
  • Södra Älvsborg Hospital

    collaborator OTHER
  • Karolinska University Hospital

    collaborator OTHER
  • University Hospital, Linkoeping

    collaborator OTHER
  • Sunderby Hospital

    collaborator OTHER
  • Capio Sankt Görans Hospital

    collaborator OTHER
  • Umeå University

    lead OTHER

Principal Investigators

  • Jonatan Salzer, MD, PhD · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2024-02-01
Completion
2025-03-12

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05056324 on ClinicalTrials.gov